Last reviewed · How we verify
NCT06808841: Sipwlefsmdfs
Sufentanil in Patients With Lower Extremity Fracture Surgery Myocardial Damage Function Study
NA trial testing Sufentanil injection in Myocardial Injury in 160 participants. Not yet recruiting.
10 May 2025
Quick facts
| Lead sponsor | Second Hospital of Shanxi Medical University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 5 February 2025 |
| Primary completion | 10 May 2025 |
| Estimated completion | 10 May 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Sufentanil injection — full drug profile →
- Placebo
Conditions studied
- Myocardial Injury — all drugs for Myocardial Injury →
Sponsor
Second Hospital of Shanxi Medical University
Who can join
Adults 18 to 65, any sex, with Myocardial Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. To analyze the association of different doses of opioids on myocardial injury/protection through BMP-6/SMAD pathway. 2. To observe the effect of different doses of opioids on the expression of BMP-6 in bone marrow. 3. To investigate the relationship between different doses of opioids and BMP-6 and perioperative cardiovascular adverse events in patients with lower extremity fracture surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06808841
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sufentanil injection
Trials testing the same drug.
- NCT06382961 — Postoperative Dexmedetomidine in Prevention of Postoperative Delirium · NA · completed
- NCT06000137 — The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy · NA · completed
- NCT05028049 — Comparison of Remifentanil-induced Postoperative Hyperalgesia Between Patients From Plain Area and Plateau Area · unknown
Other recruiting trials for Myocardial Injury
Currently open trials in the same condition.
- NCT06982404 — ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biop · recruiting
- NCT06279000 — Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery · Phase 3 · recruiting
- NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting
- NCT06705023 — Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an · Phase 2 · recruiting
- NCT06296212 — Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial In · Phase 3 · recruiting
Other Second Hospital of Shanxi Medical University trials
Trials by the same sponsor.
- NCT07280663 — Correlation Between Neurofilament Light Chain and Remazolam Sensitivity in Elderly Adults · EARLY_PHASE1 · completed
- NCT07012902 — Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia · EARLY_PHASE1 · not yet recruiting
- NCT06990763 — Network Pharmacology Was Applied to Explore the Mechanism of Remimazolam Applied in General Anesthesia for Gynecological · NA · not yet recruiting
- NCT06991985 — Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section · not yet recruiting
- NCT06947551 — The Mechanism of Endogenous Nociceptin/Orphanin FQ(N/OFQ) and β1-adrenoceptor Autoantibody in Promoting Ischemic Arrhyth · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06808841 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Second Hospital of Shanxi Medical University
- Last refreshed: 5 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06808841.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing